Clinical Trial Update: Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of cabozantinib for locally advanced renal cell carcinoma has posted results. The study includes patients with clear cell histology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Emory University | Conditions: Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-08-13